Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Recurrence 1 Neoplasms 1 Melanoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 23 fludarabine phosphate 20 Cyclophosphamide 18 Mycophenolic Acid 16 Whole-Body Irradiation 15 Cyclosporine 15 Busulfan 12 Tacrolimus 11 Methotrexate 10 Antilymphocyte Serum 9 Radiotherapy 8 Melphalan 8 Etoposide 8 pembrolizumab 7 Methylprednisolone 6 Filgrastim 6 Sirolimus 4 Prednisone 4 Nivolumab 4 sargramostim 3 Vincristine 3 Transplantation 3 Therapeutics 3 Polymerase Chain Reaction 3 Cord Blood Stem Cell Transplantation 3 Amplified Fragment Length Polymorphism Analysis 3 mogamulizumab 2 merphos 2 bempegaldesleukin 2 Voriconazole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Tranexamic Acid × Dermatologic × Clear all

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡